Clinical Trials Browser

Active not recruiting × OTHER × Penile Neoplasms × Clear all

Kidney Neoplasms, Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Urologic Neoplasms

NCT02721732 2026-01-29

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Adrenal Cortex Neoplasms, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms, Unknown Primary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Carcinoma, Small Cell, Vascular Neoplasms

NCT03333616 2026-01-21

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Phase 2 Active not recruiting

100 enrolled

EndocrineGenitourinary

Penile Neoplasms, Urogenital Neoplasms, Adrenocortical Carcinoma, Carcinoma, Small Cell

NCT03391479 2025-12-18

A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy

Phase 2 Active not recruiting

25 enrolled

Genitourinary

Neoplasm Metastasis, Penile Neoplasms

NCT02817958 2025-06-26

MEGACEP

Phase 2 Active not recruiting

37 enrolled

Genitourinary

Carcinoma, Squamous Cell, Penile Neoplasms

NCT05592639 2025-05-16

VELRAD

Phase NA Active not recruiting

50 enrolled

DermatologicGenitourinary

Melanoma, Penile Neoplasms

Clinical Trials

LIAM Mc

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy

MEGACEP

VELRAD